ICOC Meeting December 2018

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE AND
THE APPLICATION REVIEW SUBCOMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

Date: December 13^th, 2018

Time: 10:00 a.m. to 1:00p.m.

 

Main Location

• CIRM 1999 Harrison Street Suite 1650, Oakland, CA 94612

Other Locations: 

• 1001 Health Sciences Rd., Irvine, CA 92697-3950
• 291 Campus Drive, Stanford, CA
• 9301 Wilshire Blvd. Ste. 507 Beverly Hills CA 90210
• 4610 X Street, Suite 3101, Sacramento, CA 95817
• 2619 Montclair St, San Diego, CA 92104
• 100 Kimball Way, South San Francisco, CA 94080

• 8700 Beverly Blvd, Room 2015, Los Angeles, CA 90048

 

Dial-In and WebEx Information

Dial-In information:

• Dial-In Number:  (800) 398-9367  
• Confirmation Number: 457808

WebEx Link

• https://cirm.webex.com/cirm/onstage/g.php?MTID=eb6c9498e2cb629adc841bb27746278cc

Conference Cast Link

• https://im.csgsystems.com/cgi-bin/confCast
• Conference ID#:  457808

 

Open Session

1. Call to Order.
    
2. Roll Call.
    
3. Chairman’s Report.
    
4. President’s Report

Discussion and Action Items

5. Consideration of applications submitted in response to Clinical Trial Stage Projects (CLIN 1).

• Clinical Presentation
• CLIN2-11371Public Summary
• Letter to the board CLIN2-11371

6. Consideration of resolution honoring CIRM Board Member Dr. Bertram Lubin.

Closed Session

7. Discussion of Personnel [Evaluation of President] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(f)(3)(D)).
    
8. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications submitted in response to agenda items “5”. (Health & Safety Code 125290.30(f) (3) (B) and (C)).
    

Discussion and Action Items

9. Public Comment.
    
10. Adjournment.

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE** 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 510-340-9111 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Douglas Guillen at the California Institute for Regenerative Medicine at dguillen@cirm.ca.gov or 510-340-9111.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov

---